Arvinas, Inc. (ARVN) Tops Q1 EPS by 214c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Oil rally pressures S&P, Nasdaq; Microsoft, Salesforce buoy Dow
- Oil prices rise 2% as attacks on Saudi Arabia overshadow Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
- One dead in new attack on Saudi airport, a day after Houthi strike kills 13
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Lumentum shares fall after hitting 52-week high
Arvinas Inc. (ARVN) PT Lowered to $16 at BTIG
May 2, 2025 5:35 AM EDTBTIG analyst Jeet Mukherjee lowered the price target on Arvinas Inc. (NASDAQ: ARVN) to $16.00 (from $69.00) while maintaining a Buy rating.
The analyst comments "ARVN reported 1Q25 earnings, and together with partner Pfizer (PFE, Not Rated), announced a re-prioritization of vepdegestrant's development... More



